Vascular Solutions Company Profile (NASDAQ:VASC)

About Vascular Solutions

Vascular Solutions logoVascular Solutions, Inc. is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company's product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world. Its products include GuideLiner catheters, Pronto catheters, Vein catheter reprocessing, Micro-introducer kits, Hemostatic patches, Radial access products, Langston catheters and D-Stat Flowable hemostat. The Company's product portfolio includes a spectrum of over 90 products consisting of approximately 900 stock keeping units (SKUs) covering an array of blood clotting devices, extraction catheters, access catheters, guide extension catheters, micro-introducer kits, guidewires, snare and retrieval devices, a reprocessing service for radiofrequency catheters and a laser and procedure kits for the treatment of varicose veins.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Supplies
  • Exchange: NASDAQ
  • Symbol: VASC
  • CUSIP: 92231M10
Key Metrics:
  • Previous Close: $48.63
  • 50 Day Moving Average: $48.17
  • 200 Day Moving Average: $42.51
  • 52-Week Range: $24.34 - $50.72
  • Trailing P/E Ratio: 90.06
  • Foreward P/E Ratio: 33.54
  • P/E Growth: 1.91
  • Market Cap: $850.59M
  • Outstanding Shares: 17,491,000
  • Beta: 0.54
  • Net Margins: 6.22%
  • Return on Equity: 16.32%
  • Return on Assets: 14.53%
  • Current Ratio: 5.86%
  • Quick Ratio: 4.20%
Additional Links:
Companies Related to Vascular Solutions:

Analyst Ratings

Consensus Ratings for Vascular Solutions (NASDAQ:VASC) (?)
Ratings Breakdown: 1 Hold Rating, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $48.88 (0.50% upside)

Analysts' Ratings History for Vascular Solutions (NASDAQ:VASC)
DateFirmActionRatingPrice TargetDetails
10/6/2016Needham & Company LLCInitiated CoverageBuy$58.00View Rating Details
8/10/2016Canaccord GenuityReiterated RatingBuyView Rating Details
7/26/2016Piper Jaffray Cos.Boost Price TargetOverweight$45.00 -> $49.00View Rating Details
7/12/2016SidotiDowngradeBuy -> Neutral$47.00View Rating Details
12/5/2014DA DavidsonInitiated CoverageBuyView Rating Details
(Data available from 10/24/2014 forward)


Earnings History for Vascular Solutions (NASDAQ:VASC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/24/2016Q3$0.30$0.31$41.64 million$41.80 millionViewListenView Earnings Details
7/25/2016Q216$0.30$0.33$41.40 million$41.20 millionViewListenView Earnings Details
4/25/2016Q116$0.23$0.25$38.37 million$39.00 millionViewListenView Earnings Details
1/21/2016Q415$0.27$0.33$37.53 million$38.09 millionViewListenView Earnings Details
10/20/2015Q315$0.25$0.27$36.41 million$37.00 millionViewListenView Earnings Details
7/21/2015Q215$0.25$0.29$35.59 million$37.60 millionViewListenView Earnings Details
4/21/2015Q115$0.18$0.21$33.38 million$34.61 millionViewN/AView Earnings Details
2/3/2015Q414$0.18$0.23$32.82 million$33.60 millionViewN/AView Earnings Details
10/21/2014Q314$0.20$0.15$31.10 million$31.90 millionViewListenView Earnings Details
7/22/2014Q214$0.18$0.20$30.43 million$30.70 millionViewN/AView Earnings Details
4/22/2014Q114$0.18$0.16$29.91 million$29.91 millionViewListenView Earnings Details
2/4/2014Q413$0.19$0.22$28.61 million$29.10 millionViewListenView Earnings Details
10/22/2013Q313$0.07$0.19$27.10 million$28.01 millionViewListenView Earnings Details
7/23/2013Q2 2013$0.17$0.17$27.00 million$27.40 millionViewN/AView Earnings Details
4/23/2013Q1 2013$0.15$0.16$26.51 million$26.10 millionViewListenView Earnings Details
2/5/2013Q4 2012$0.17$0.18$25.59 million$25.30 millionViewListenView Earnings Details
10/18/2012$0.15$0.16ViewN/AView Earnings Details
7/24/2012$0.13$0.15ViewN/AView Earnings Details
2/1/2012$0.13$0.13ViewN/AView Earnings Details
10/25/2011$0.17$0.10ViewN/AView Earnings Details
8/2/2011$0.12$0.13ViewN/AView Earnings Details
4/19/2011$0.10$0.10ViewN/AView Earnings Details
2/1/2011$0.12$0.12ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Vascular Solutions (NASDAQ:VASC)
Current Year EPS Consensus Estimate: $1.24 EPS
Next Year EPS Consensus Estimate: $1.45 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.23$0.23$0.23
Q2 20161$0.30$0.30$0.30
Q3 20161$0.30$0.30$0.30
Q4 20161$0.34$0.34$0.34
(Data provided by Zacks Investment Research)


Dividend History for Vascular Solutions (NASDAQ:VASC)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Vascular Solutions (NASDAQ:VASC)
Insider Ownership Percentage: 6.90%
Institutional Ownership Percentage: 81.23%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/27/2016Howard RootCEOSell40,000$45.11$1,804,400.00View SEC Filing  
7/27/2016William RutsteinVPSell10,011$46.26$463,108.86View SEC Filing  
5/24/2016Howard RootCEOSell34,418$39.05$1,344,022.90View SEC Filing  
5/13/2016James HennenCFOSell11,785$38.12$449,244.20View SEC Filing  
5/13/2016Martin J EmersonDirectorSell20,000$37.93$758,600.00View SEC Filing  
4/28/2016John L ErbDirectorSell10,000$35.58$355,800.00View SEC Filing  
4/27/2016Howard RootCEOSell15,582$36.07$562,042.74View SEC Filing  
4/27/2016Timothy SlaytonInsiderSell2,994$36.72$109,939.68View SEC Filing  
2/29/2016Charmaine SuttonVPSell14,325$30.13$431,612.25View SEC Filing  
11/19/2015Jorge SaucedoDirectorSell7,715$33.45$258,066.75View SEC Filing  
11/4/2015Richard NigonDirectorSell8,000$32.40$259,200.00View SEC Filing  
11/2/2015Howard RootCEOSell18,062$32.03$578,525.86View SEC Filing  
10/26/2015Carrie PowersVPSell5,412$32.77$177,351.24View SEC Filing  
8/20/2015Jorge SaucedoDirectorSell2,285$38.00$86,830.00View SEC Filing  
7/23/2015Timothy SlaytonInsiderSell1,587$38.61$61,274.07View SEC Filing  
5/28/2015Richard NigonDirectorSell6,000$32.68$196,080.00View SEC Filing  
5/4/2015Howard RootCEOSell25,000$32.62$815,500.00View SEC Filing  
4/27/2015Carrie PowersVPSell6,000$34.90$209,400.00View SEC Filing  
4/24/2015James HennenCFOSell4,792$35.66$170,882.72View SEC Filing  
2/10/2015William RutsteinVPSell10,814$26.91$291,004.74View SEC Filing  
2/5/2015James HennenCFOSell11,301$27.62$312,133.62View SEC Filing  
2/5/2015Jorge SaucedoDirectorSell10,000$27.36$273,600.00View SEC Filing  
11/26/2014Richard NigonDirectorBuy3,000$25.80$77,400.00View SEC Filing  
11/14/2014Richard W KrampDirectorBuy1,475$23.69$34,942.75View SEC Filing  
4/24/2014Timothy SlaytonInsiderSell1,390$23.15$32,178.50View SEC Filing  
2/27/2014James HennenCFOSell10,000$25.42$254,200.00View SEC Filing  
2/25/2014Howard RootCEOSell50,000$24.74$1,237,000.00View SEC Filing  
2/25/2014Richard NigonDirectorBuy1,000$25.66$25,660.00View SEC Filing  
2/14/2014Howard RootCEOSell25,000$25.13$628,250.00View SEC Filing  
2/11/2014Paul O'connellDirectorSell2,000$24.43$48,860.00View SEC Filing  
2/10/2014William RutsteinVPSell27,782$23.80$661,211.60View SEC Filing  
10/28/2013James HennenCFOSell10,000$19.72$197,200.00View SEC Filing  
10/25/2013Jorge SaucedoDirectorSell2,000$19.70$39,400.00View SEC Filing  
7/26/2013Charmaine SuttonVPSell7,538$16.15$121,738.70View SEC Filing  
7/25/2013Howard RootCEOSell21,580$16.10$347,438.00View SEC Filing  
7/25/2013Howard RootCEOSell21,580$16.10$347,438.00View SEC Filing  
7/25/2013Paul O'connellDirectorSell30,000$16.11$483,300.00View SEC Filing  
5/17/2013Paul O'connellDirectorSell10,000$16.05$160,500.00View SEC Filing  
5/1/2013Richard NigonDirectorBuy3,000$15.57$46,710.00View SEC Filing  
11/26/2012Susan ChristianVPSell7,648$14.41$110,207.68View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Vascular Solutions (NASDAQ:VASC)
DateHeadline logoVascular Solutions Reports Third Quarter Results (NASDAQ:VASC) - October 24 at 7:35 PM logoVASCULAR SOLUTIONS INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) (NASDAQ:VASC) - October 24 at 7:35 PM logoVascular Solutions posts 3Q profit (NASDAQ:VASC) - October 24 at 7:35 PM logoQ3 2016 Vascular Solutions Inc Earnings Release - After Market Close (NASDAQ:VASC) - October 24 at 7:45 AM logoVascular : Receives 510(k) Clearance for Fluent Inflation Device (NASDAQ:VASC) - October 23 at 7:52 AM
News IconVascular Solutions Fluent Inflation Device Receive FDA Clearance (NASDAQ:VASC) - October 23 at 7:52 AM logoMedical Product Stocks' Oct 24 Earnings Preview: ELGX, VASC (NASDAQ:VASC) - October 21 at 11:36 AM logoVascular Solutions Receives 510(k) Clearance for Fluent™ Inflation Device (NASDAQ:VASC) - October 21 at 11:36 AM logoBRIEF-Vascular solutions announces ind submission for replas freeze-dried plasma (NASDAQ:VASC) - October 19 at 7:34 PM logoVascular Solutions (VASC) Announces Submission of RePlas IND to FDA (NASDAQ:VASC) - October 19 at 7:34 PM logoVascular Solutions, Inc. : quaterly earnings release (NASDAQ:VASC) - October 19 at 7:34 PM logoFacetime: Howard Root, CEO and co-founder, Vascular Solutions Inc. (NASDAQ:VASC) - October 19 at 7:34 PM logoVascular Solutions Announces IND Submission for RePlas™ Freeze-Dried Plasma (NASDAQ:VASC) - October 18 at 8:09 AM logoShares of VASC Up 19.4% Since Uptrend Call on Shares (NASDAQ:VASC) - October 12 at 12:52 PM logoVascular Solutions, Inc. breached its 50 day moving average in a Bearish Manner : VASC-US : October 10, 2016 (NASDAQ:VASC) - October 10 at 7:23 PM
News IconVascular Solutions Issues Recall of Twin-Pass Dual Access Catheters (NASDAQ:VASC) - October 7 at 7:36 PM
News IconVascular Solutions, Inc. recalls Twin-Pass® Dual Access Catheters (NASDAQ:VASC) - October 7 at 7:36 PM logoNeedham Starts Coverage on Vascular Solutions, Inc. (VASC) Giving It An Initial Rating Of “Buy” (NASDAQ:VASC) - October 7 at 7:36 PM logoVascular Solutions Announces Q3 Earnings Date (NASDAQ:VASC) - October 5 at 7:46 PM logo4:05 pm Vascular Solutions initiates a nationwide recall of Twin-Pass Dual Access catheters used in catheterization procedures (NASDAQ:VASC) - October 4 at 7:22 PM logoVascular Solutions, Inc. Issues Recall of Twin-Pass® Dual Access Catheters (NASDAQ:VASC) - October 4 at 7:22 PM logoVascular Solutions, Inc. – Value Analysis (NASDAQ:VASC) : October 3, 2016 (NASDAQ:VASC) - October 3 at 7:22 PM logoShares of VASC Up 21.5% Since Uptrend Call on Shares (NASDAQ:VASC) - October 2 at 7:43 AM logoVascular Solutions, Inc. breached its 50 day moving average in a Bearish Manner : VASC-US : September 30, 2016 (NASDAQ:VASC) - September 30 at 7:10 PM
News IconSkyworks Solutions Inc.'s (SWKS): Seeing Active Stock of Yesterday (NASDAQ:VASC) - September 23 at 7:35 AM logo27.8% Return Seen to Date on SmarTrend Vascular Solutions Call (VASC) (NASDAQ:VASC) - September 23 at 7:35 AM
News IconUSAMMDA and Freeze-Dried Plasma: A Story of Success (NASDAQ:VASC) - September 16 at 11:35 AM logoShares of VASC Up 23.9% Since Uptrend Call on Shares (NASDAQ:VASC) - September 15 at 8:02 PM logoVascular Solutions Surpasses 150,000 Successfully Reprocessed ClosureFAST® Catheters (NASDAQ:VASC) - September 14 at 12:19 PM logoVaricose Vein Treatment Market Analysis By Treatment Mode (Sclerotherapy, Endovenous Ablation, Stripping, … (NASDAQ:VASC) - September 7 at 11:47 AM logoUptrend Call Working As Vascular Solutions Stock Rises 24.1% (VASC) (NASDAQ:VASC) - August 30 at 7:50 PM logoETF’s with exposure to Vascular Solutions, Inc. : August 30, 2016 (NASDAQ:VASC) - August 30 at 7:50 PM logo19.8% Return Seen to Date on SmarTrend Vascular Solutions Call (VASC) (NASDAQ:VASC) - August 19 at 7:54 PM
News IconVaricose vein treatment market in North America and Europe worth 289.7 million USD by 2021 according to new research report (NASDAQ:VASC) - August 19 at 11:01 AM logoETF’s with exposure to Vascular Solutions, Inc. : August 17, 2016 (NASDAQ:VASC) - August 17 at 8:25 PM
News IconVaricose Vein Treatment Market To Gain From Enhanced Demand In End-use Industries Till 2024: Grand View Research, Inc. (NASDAQ:VASC) - August 17 at 11:00 AM
News IconVascular Access Systems Market Share and Key Trends 2016-2026 (NASDAQ:VASC) - August 16 at 11:26 AM
News IconMarket Research on Vascular Access Systems Market 2016 and Analysis to 2026 (NASDAQ:VASC) - August 12 at 8:13 PM logoVascular Solutions Up 19.6% Since SmarTrend Uptrend Call (VASC) (NASDAQ:VASC) - August 12 at 8:13 PM logoNew Market Research Report: Vascular Solutions, Inc. (VASC) - Medical Equipment - Deals and Alliances Profile (NASDAQ:VASC) - August 12 at 8:13 PM
News IconCardiovascular Systems Releases 30-Day Results from Liberty 360° Study in Late-Breaking Presentation at 2016 Amputation Prevention Symposium (NASDAQ:VASC) - August 11 at 11:33 AM
News IconCorindus Vascular Robotics and ACIST Medical Systems Collaborate to Improve Percutaneous Coronary Intervention … – Business Wire (press release) (NASDAQ:VASC) - August 11 at 11:33 AM logoBRIEF-Vascular Solutions files for mixed shelf of up to $50 mln - SEC filing (NASDAQ:VASC) - August 10 at 5:25 PM logoSelf-Expanding Peripheral Vascular Stents Market: Global Industry Analysis and Forecast 2016 - 2024 (NASDAQ:VASC) - August 4 at 11:22 AM logoVascular Solutions, Inc. :VASC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 1, 2016 (NASDAQ:VASC) - August 1 at 7:51 PM logoVASCULAR SOLUTIONS INC Financials (NASDAQ:VASC) - July 29 at 1:04 PM logoVascular Solutions to Present at the Canaccord Genuity Growth Conference (NASDAQ:VASC) - July 27 at 4:05 PM logoVascular Solutions, Inc. :VASC-US: Earnings Analysis: Q2, 2016 By the Numbers : July 27, 2016 (NASDAQ:VASC) - July 27 at 3:27 PM
News IconFederal Jury Convicts Two Former Acclarent, Inc. Executives on Misdemeanor Charges Related to Off-Label Marketing of Medical... (NASDAQ:VASC) - July 26 at 8:38 PM logoRecent Off-Label Drug Cases Are A Road Map For The Future (NASDAQ:VASC) - July 26 at 8:38 PM


Vascular Solutions (NASDAQ:VASC) Chart for Monday, October, 24, 2016

Last Updated on 10/24/2016 by Staff